Address
Email address
Phone number
Valikus üle 8000 toote - pea nõu apteekriga ja telli ravimid koju kiirkulleriga või tasuta enda lähimasse apteeki. Üle 700 sooduspakkumise. Kiire tarne!
Name
osaühing TARTU UUSAPTEEK
Registry code
10050453
VAT number
EE100569810
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
20.06.1996 (28)
Financial year
01.01-31.12
Capital
10 272.00 €
Activity
47731 - Dispensing chemist in specialised stores
16 978 132 €
48 646 €
0%
2 181 €
(estimate is approximate)
418 389 €
22
Submitted
No tax arrears
12%
2%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Omanikukonto: PIRET UIBOKAND 08.12.1966 (57) | 51% - 5 239.00 EUR | Board member | Direct ownership | |
Apteekide Infotehnoloogia OÜ 10681604 | 49% - 5 033.00 EUR | - | - |
2019 30.06.2020 | 2020 30.06.2021 | 2021 30.06.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
---|---|---|---|---|---|
Total Revenue | 13 625 017 € | 13 783 699 € | 14 402 520 € | 14 868 565 € | 16 978 132 € |
Net profit (loss) for the period | -180 834 € | 30 018 € | 83 925 € | 96 598 € | 48 646 € |
Profit Margin | -1% | 0% | 1% | 1% | 0% |
Current Assets | 2 226 027 € | 2 090 239 € | 2 251 818 € | 2 255 774 € | 2 661 446 € |
Fixed Assets | 24 839 € | 68 341 € | 57 357 € | 45 461 € | 35 824 € |
Total Assets | 2 250 866 € | 2 158 580 € | 2 309 175 € | 2 301 235 € | 2 697 270 € |
Current Liabilities | 2 091 664 € | 1 969 360 € | 2 036 030 € | 1 931 492 € | 2 278 881 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 159 202 € | 189 220 € | 273 145 € | 369 743 € | 418 389 € |
Employees | 23 | 22 | 21 | 21 | 22 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 4 682 430.53 € | 109 088.23 € | 81 550.37 € | 30 |
2023 Q4 | 4 471 898.71 € | 89 042.24 € | 74 063.45 € | 30 |
2023 Q3 | 4 158 021.58 € | 83 329.85 € | 77 714.4 € | 31 |
2023 Q2 | 4 537 052.04 € | 80 823.13 € | 74 123.71 € | 31 |
2023 Q1 | 4 041 125.21 € | 98 252.78 € | 78 431.78 € | 31 |
2022 Q4 | 3 921 650.82 € | 78 527.23 € | 67 837 € | 31 |
2022 Q3 | 3 648 808.36 € | 73 108.75 € | 66 926.02 € | 28 |
2022 Q2 | 4 016 622.55 € | 85 794.38 € | 63 987.13 € | 25 |
2022 Q1 | 3 720 192.71 € | 100 044.99 € | 69 809.88 € | 28 |
2021 Q4 | 3 968 514.85 € | 74 220.99 € | 59 840.65 € | 28 |
2021 Q3 | 3 375 441.03 € | 76 051.92 € | 61 413.51 € | 28 |
2021 Q2 | 3 854 725.27 € | 89 478.17 € | 69 832.49 € | 28 |
2021 Q1 | 3 616 764.07 € | 94 634.2 € | 71 791.81 € | 32 |
2020 Q4 | 3 946 733.28 € | 74 790.38 € | 62 255.97 € | 32 |
2020 Q3 | 3 381 831.11 € | 77 004.23 € | 65 382.97 € | 32 |
2020 Q2 | 3 352 515.97 € | 81 855.49 € | 62 243.28 € | 30 |
2020 Q1 | 3 716 711.12 € | 98 851.06 € | 74 878.15 € | 30 |